Bicocca Open Archive

Logo unimib boa
SINICO, RENATO ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.664
AS - Asia 12.914
EU - Europa 10.022
SA - Sud America 1.876
AF - Africa 284
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 27
Totale 50.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.697
SG - Singapore 4.967
IT - Italia 2.784
CN - Cina 2.365
HK - Hong Kong 2.205
CA - Canada 1.791
RU - Federazione Russa 1.739
BR - Brasile 1.421
IE - Irlanda 1.283
VN - Vietnam 1.267
SE - Svezia 901
DE - Germania 858
GB - Regno Unito 545
FR - Francia 510
BD - Bangladesh 484
UA - Ucraina 374
TR - Turchia 339
FI - Finlandia 314
IN - India 288
AT - Austria 237
AR - Argentina 158
IQ - Iraq 132
JP - Giappone 129
KR - Corea 125
MX - Messico 98
PK - Pakistan 97
ES - Italia 85
ZA - Sudafrica 81
NL - Olanda 80
ID - Indonesia 77
SA - Arabia Saudita 76
EC - Ecuador 66
DK - Danimarca 62
CO - Colombia 59
VE - Venezuela 57
PH - Filippine 55
UZ - Uzbekistan 47
PL - Polonia 42
CL - Cile 40
EG - Egitto 40
MA - Marocco 32
MY - Malesia 31
EU - Europa 30
PY - Paraguay 29
RO - Romania 29
BE - Belgio 25
KE - Kenya 25
IL - Israele 24
GR - Grecia 23
AU - Australia 22
AE - Emirati Arabi Uniti 20
TH - Thailandia 20
UY - Uruguay 20
JO - Giordania 19
PE - Perù 19
DZ - Algeria 18
OM - Oman 17
JM - Giamaica 16
LT - Lituania 16
TN - Tunisia 16
CH - Svizzera 15
ET - Etiopia 15
NP - Nepal 15
PT - Portogallo 15
IR - Iran 14
CZ - Repubblica Ceca 13
KZ - Kazakistan 13
LB - Libano 13
AL - Albania 12
AZ - Azerbaigian 11
BG - Bulgaria 11
BH - Bahrain 10
CR - Costa Rica 10
NO - Norvegia 10
PS - Palestinian Territory 10
HN - Honduras 9
PA - Panama 9
HU - Ungheria 8
NG - Nigeria 8
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
AO - Angola 6
KG - Kirghizistan 6
SN - Senegal 6
DO - Repubblica Dominicana 5
GA - Gabon 5
MD - Moldavia 5
NI - Nicaragua 5
SC - Seychelles 5
TW - Taiwan 5
CI - Costa d'Avorio 4
CY - Cipro 4
HR - Croazia 4
KH - Cambogia 4
LY - Libia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BO - Bolivia 3
Totale 50.747
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.898
Singapore 2.883
Hong Kong 2.172
Woodbridge 2.066
Ashburn 1.505
Toronto 1.393
Chandler 1.358
Houston 1.248
Dublin 1.220
Fairfield 1.045
San Jose 920
Dearborn 832
Wilmington 801
Jacksonville 786
Milan 743
New York 659
Princeton 540
Frankfurt am Main 530
Chicago 439
The Dalles 432
Seattle 422
Ho Chi Minh City 396
Dallas 380
Cambridge 360
Los Angeles 352
Santa Clara 346
Beijing 317
Hanoi 268
Nanjing 258
Moscow 250
Lawrence 243
Lauterbourg 241
Altamura 212
Vienna 208
Lachine 195
Boardman 191
Rome 163
Buffalo 143
Shanghai 139
São Paulo 130
Lissone 124
San Diego 112
Hefei 109
Council Bluffs 108
Ottawa 103
Seoul 95
Guangzhou 94
Andover 83
Helsinki 76
Nanchang 76
Shenyang 74
Tokyo 69
London 65
Munich 64
Hebei 60
Norwalk 59
Columbus 58
Orem 56
Baghdad 55
Falls Church 54
Changsha 52
Nuremberg 52
Tianjin 51
Washington 49
Jakarta 48
Turin 47
Salt Lake City 46
Da Nang 45
Rio de Janeiro 43
Jiaxing 42
Tashkent 41
Jinan 40
Phoenix 39
Dhaka 38
Brooklyn 36
Denver 36
Haiphong 36
Mountain View 36
Naples 36
Atlanta 34
Florence 34
Montreal 34
Warsaw 34
Dong Ket 33
Philadelphia 33
Belo Horizonte 32
San Francisco 32
Zhengzhou 32
Jeddah 31
Chennai 28
Lahore 28
Figino 27
Johannesburg 27
New Delhi 27
Tampa 26
Hangzhou 25
Redmond 25
Boston 24
Curitiba 24
Istanbul 24
Totale 33.705
Salva come PNG Salva come JPEG
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 702
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 598
Modifications in peripheral-blood lymphocyte subpopulations induced by plasmapheresis and immunosuppressive drugs 488
Microscopic Polyangiitis 425
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 401
MALDI imaging in Fabry nephropathy: a multicenter study 398
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 391
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 384
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 381
Kidney Involvement 373
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 354
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 347
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 328
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 326
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 312
Renal involvement in Churg-Strauss syndrome 300
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 298
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 295
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 294
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 287
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 285
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 281
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 279
Neutrophil Extracellular Traps in the Autoimmunity Context 277
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 274
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 273
Novel Therapies in Takayasu Arteritis 263
Eosinophilic granulomatosis with polyangiitis (churg-straus syndrome) 262
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 261
117. Prediction of Long-Term Evolutionary Profiles in Eosinophilic Granulomatosis with Polyangiitis (Churg– Strauss) Based on Baseline and Follow-Up Characteristics 259
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 258
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 257
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 256
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 255
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 255
Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies 254
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 250
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion 249
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study 247
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 243
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 240
Systemic Vasculitis and Pregnancy: a Multicenter Study On Maternal and Neonatal Outcome of 43 Prospectively Followed Pregnancies 239
CLINICAL FEATURES AND RENAL PROGNOSIS IN LUPUS NEPHRITIS PATIENTS UNDERGOING A REPEATED BIOPSY: RESULTS OF 103 RE-BIOPSIES IN 438 PATIENTS 239
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 238
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 237
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 235
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 234
Immunology of membranous nephropathy: From animal models to humans 233
Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy 232
Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients 229
RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS 228
Milder clinical presentation of lupus nephritis and improved renal survival during the last 50 years: a multicentric study 228
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 228
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 227
Goodpasture syndrome and anti-glomerular basement membrane disease 223
Sneddon's syndrome: clinical and immunohistochemical findings 221
Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity? 220
Evidence for charge-based mimicry in anti dsDNA antibody generation 219
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 218
Anticoagulant-related nephropathy: a pathological note 218
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome 217
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature 217
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 216
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 216
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 215
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 215
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 215
T-lymphocyte subsets in primary and secondary glomerulonephritis 212
ANCA-associated vasculitis in childhood: Recent advances 211
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 211
Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis 211
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 210
Multiple hepatic abscesses complicating continuous ambulatory peritoneal dialysis 210
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 209
Plasma-exchange and glomerulonephritis 208
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases 208
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 208
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 206
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 205
Role and clinical significance of rheumatoid factors in glomerulonephritis 205
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis [Position paper] 204
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 203
255. Renal involvement in EGPA: a multicentre retrospective study of 63 cases 201
Lymphocyte populations in the peripheral blood from patients with IgA nephropathy 199
Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis 199
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies 199
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 198
alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications 197
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide 197
Renal involvement in eosinophilic granulomatosis with polyangiitis 195
Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease) 195
ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE) 195
B lymphocyte subpopulations and T-cell subsets in primary chronic glomerulonephritis 193
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 193
P0346THE EFFECTS OF RITUXIMAB MAINTENANCE THERAPY ON LUPUS NEPHRITIS 193
A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: A retrospective study of 47 patients 192
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 192
Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: A comparison of different assays 190
European consensus statement on the terminology used in the management of lupus glomerulonephritis 189
Plasma-exchange in immunologically mediated glomerular diseases 189
Totale 25.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021271 0 0 0 0 0 0 0 0 0 0 0 271
2021/20222.909 153 295 405 193 210 197 143 152 134 167 311 549
2022/20234.801 660 1.264 341 370 411 810 48 225 403 40 145 84
2023/20243.668 125 126 133 145 514 939 752 94 328 59 58 395
2024/20257.801 481 894 322 373 774 247 622 356 806 1.071 527 1.328
2025/202617.379 1.411 668 1.314 1.278 2.022 1.014 2.108 866 1.521 1.199 2.285 1.693
Totale 52.135